HB 1033
  • Introduced
    Jan 05, 2021
  • Passed House
    Feb 23, 2021
  • Passed Senate
    Mar 22, 2021
  • Became Law
    Apr 20, 2021
HB 1033
North Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Relating to prescribing of biosimilar drugs.
Last Action See all actions
executive • Apr 21, 2021: Filed with Secretary Of State 04/20
Latest Bill Text See all bill texts
Enrollment

Summary

Comments on HB 1033

Tweets

Whip Lists

Sponsors
Votes
Feb 23, 2021, House
The question being on the final passage of the amended bill, which has been read, and has committee recommendation of DO PASS, the roll was called and there were 92 YEAS, 1 NAYS, 0 EXCUSED, 1 ABSENT AND NOT VOTING.
YES: 92
NO: 1
OTHER: 1
YES: 92

NO: 1

ABSENT: 1

Sources
Mar 22, 2021, Senate
The question being on the final passage of the amended bill, which has been read, and has committee recommendation of DO PASS, the roll was called and there were 47 YEAS, 0 NAYS, 0 EXCUSED, 0 ABSENT AND NOT VOTING.
YES: 47
NO: 0
OTHER: 0
YES: 47

NO: 0

    OTHER: 0
    Sources
    Apr 13, 2021, House
    The question being on the final passage of the amended bill, which has been read, the roll was called and there were 94 YEAS, 0 NAYS, 0 EXCUSED, 0 ABSENT AND NOT VOTING.
    YES: 94
    NO: 0
    OTHER: 0
    YES: 94

    NO: 0

      OTHER: 0
      Sources
      Actions
      • Apr 21, 2021 | executive
        • Filed with Secretary Of State 04/20
      • Apr 20, 2021 | House
        • Signed by Governor 04/19
      • Apr 16, 2021 | House
        • Signed by Speaker
        • Sent to Governor
      • Apr 15, 2021 | Senate
        • Signed by President
      • Apr 13, 2021 | House
        • Concurred
        • Second reading, passed, yeas 94 nays 0
      • Mar 23, 2021 | House
        • Returned to House (12)
      • Mar 23, 2021 | Senate
        • Committee Work, Senate Human Services, 03/23 10:30 AM, Room Sakakawea - Committee Work: Committee Work: Relating to prescribing of biosimilar drugs.
      • Mar 22, 2021 | Senate
        • Second reading, passed as amended, yeas 47 nays 0
      • Mar 19, 2021 | Senate
        • Amendment adopted, placed on calendar
      • Mar 17, 2021 | Senate
        • Reported back amended, do pass, amendment placed on calendar 6 0 0
      • Mar 10, 2021 | Senate
        • Bill Hearing, Senate Human Services, 03/10 2:30 PM, Room Sakakawea - Relating to prescribing of biosimilar drugs.
        • Committee Hearing 02:30
      • Mar 03, 2021 | Senate
        • Received from House
        • Introduced, first reading, referred Human Services Committee
      • Feb 23, 2021 | House
        • Second reading, passed, yeas 92 nays 1
      • Feb 15, 2021 | House
        • Amendment adopted, placed on calendar
      • Feb 12, 2021 | House
        • Reported back amended, do pass, amendment placed on calendar 13 1 0
      • Jan 06, 2021 | House
        • Bill Hearing, House Human Services, 01/06 10:45 AM, Room Pioneer - Prescribing of biosimilar drugs
        • Committee Hearing 10:45
      • Jan 05, 2021 | House
        • Introduced, first reading, referred Human Services Committee
      Bill Texts
      Documents
      Sources